Literature DB >> 16673007

Mechanisms of disease: the hygiene hypothesis revisited.

Francisco Guarner1, Raphaëlle Bourdet-Sicard, Per Brandtzaeg, Harsharnjit S Gill, Peter McGuirk, Willem van Eden, James Versalovic, Joel V Weinstock, Graham A W Rook.   

Abstract

In industrialized countries the incidence of diseases caused by immune dysregulation has risen. Epidemiologic studies initially suggested this was connected to a reduction in the incidence of infectious diseases; however, an association with defects in immunoregulation is now being recognized. Effector T(H)1 and T(H)2 cells are controlled by specialized subsets of regulatory T cells. Some pathogens can induce regulatory cells to evade immune elimination, but regulatory pathways are homeostatic and mainly triggered by harmless microorganisms. Helminths, saprophytic mycobacteria, bifidobacteria and lactobacilli, which induce immunoregulatory mechanisms in the host, ameliorate aberrant immune responses in the setting of allergy and inflammatory bowel disease. These organisms cause little, if any, harm, and have been part of human microecology for millennia; however, they are now less frequent or even absent in the human environment of westernized societies. Deficient exposure to these 'old friends' might explain the increase in immunodysregulatory disorders. The use of probiotics, prebiotics, helminths or microbe-derived immunoregulatory vaccines might, therefore, become a valuable approach to disease prevention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673007     DOI: 10.1038/ncpgasthep0471

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN: 1743-4378


  74 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Environmental factors associated with Crohn's disease in India.

Authors:  Srinivasan Pugazhendhi; Manoj Kumar Sahu; Venkataraman Subramanian; Anna Pulimood; Balakrishnan S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2011-12-13

Review 3.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.

Authors:  Harald Renz; Per Brandtzaeg; Mathias Hornef
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

4.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Authors:  Les Dethlefsen; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-16       Impact factor: 11.205

Review 5.  The use of Trichuris suis and other helminth therapies to treat Crohn's disease.

Authors:  Aditya Reddy; Bernard Fried
Journal:  Parasitol Res       Date:  2007-01-06       Impact factor: 2.289

6.  What caused the increase of autoimmune and allergic diseases: a decreased or an increased exposure to luminal microbial components?

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

Review 7.  Genes and molecules of lactobacilli supporting probiotic action.

Authors:  Sarah Lebeer; Jos Vanderleyden; Sigrid C J De Keersmaecker
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 8.  Microbes in gastrointestinal health and disease.

Authors:  Andrew S Neish
Journal:  Gastroenterology       Date:  2008-11-19       Impact factor: 22.682

Review 9.  Inflammatory bowel disease: genetic and epidemiologic considerations.

Authors:  Judy H Cho
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 10.  The gut microbiota in IBD.

Authors:  Chaysavanh Manichanh; Natalia Borruel; Francesc Casellas; Francisco Guarner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.